Jagsonpal Pharmaceuticals Limited

NSEI:JAGSNPHARM Stock Report

Market Cap: ₹16.9b

Jagsonpal Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of JAGSNPHARM?
Owner TypeNumber of SharesOwnership Percentage
State or Government409,1751.54%
Institutions412,6831.56%
Individual Insiders3,593,62413.6%
General Public5,309,68620%
Private Companies7,621,43428.7%
VC/PE Firms9,168,32034.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 14 shareholders own 79.97% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.1%
Aresko Progressive Private Limited
5,334,254₹3.4b0%no data
17.9%
Infinity Holdings Sidecar I
4,755,300₹3.0b0%no data
16.6%
Infinity Investment Management, Investment Arm
4,413,020₹2.8b-33.3%no data
8.63%
Infinity Portfolio Holdings
2,287,180₹1.5b0%no data
4.57%
Rajpal P. Kochhar
1,212,160₹773.0m0%no data
2.29%
Manish Gupta
607,604₹387.5m0%no data
1.99%
Vanaja Iyer
527,019₹336.1m0%no data
1.75%
Mukul Mahavir Agrawal
463,023₹295.3m0%no data
1.54%
Investor Education and Protection Fund (IEPF)
409,175₹260.9m0%no data
1.46%
Authum Investment & Infrastructure Limited, Asset Management Arm
387,186₹246.9m0%0.29%
1.4%
Sanjiv Dudeja
370,544₹236.3m0%no data
1.17%
Lincoln Coelho
310,200₹197.8m0%no data
0.39%
Prithipal Kochhar
103,074₹65.7m0%no data
0.096%
Acadian Asset Management LLC
25,497₹16.3m0%no data